Evaluation of novel ECG signal processing on quantification of transient ischemia and baseline wander suppression.
The performance assessment of a novel ECG signal processing technology in Fidelity 100 (test) and four modern ECG systems (controls) was conducted. A quantitative evaluation for one control and a test system was done by simultaneous recordings on 54 patients undergoing percutaneous coronary intervention (PCI) and on a biological reference signal from an ECG simulator. A qualitative performance of baseline wander suppression was done on all five systems. The results showed that the Fidelity 100 system provided excellent detection and quantification of transient ischemia and baseline wander suppression.
Kostic
Marko N
MN
Signalife, Inc., Studio City, CA 91607, USA. mkostic@signalife.com
Fakhar
Sina
S
Foxall
Tom
T
Drakulic
Budimir S
BS
Krucoff
Mitchell W
MW
D000465:Algorithms; D016477:Artifacts; D003627:Data Interpretation, Statistical; D004562:Electrocardiography / Q000295:instrumentation* / Q000379:methods*; D004867:Equipment Design; D006801:Humans; D002546:Ischemic Attack, Transient / Q000175:diagnosis* / Q000473:pathology; D017202:Myocardial Ischemia; D015203:Reproducibility of Results; D012815:Signal Processing, Computer-Assisted; D012985:Software Design; D013997:Time Factors